C-MER Eye Care Holdings Limited (HK:3309) has released an update.
C-MER Eye Care Holdings Limited has announced the application of HK$87.9 million towards share repurchases and purchases under its 2022 Share Award Scheme, reflecting the company’s confidence in its growth outlook and financial position. The company is actively considering additional share repurchases and purchases under the scheme, funded by internal cash resources, to enhance shareholder value without materially affecting its working capital or gearing level.
For further insights into HK:3309 stock, check out TipRanks’ Stock Analysis page.
